The findings of our study demonstrated that, although routinely used biomarkers such as serum CRP and synovial WBC remain valuable in diagnosing septic arthritis, incorporating novel biomarkers, such as PTX3, IL-6, and presepsin, could enhance diagnostic accuracy. This evidence concerns the gene PTX3 and bacterial arthritis.